Transplant strategies for idiopathic myelofibrosisMCCARTY, John M.Seminars in hematology. 2004, Vol 41, Num 2, pp 23-29, issn 0037-1963, 7 p., SUP3Article

Phase1/-2 study of pomalidomide in myelofibrosisMESA, Ruben A; PARDANANI, Animesh D; HUSSEIN, Kebede et al.American journal of hematology. 2010, Vol 85, Num 2, pp 129-130, issn 0361-8609, 2 p.Article

How I treat symptomatic splenomegaly in patients with myelofibrosisMESA, Ruben A.Blood. 2009, Vol 113, Num 22, pp 5394-5400, issn 0006-4971, 7 p.Article

Pathogenesis of myelofibrosis with myeloid metaplasiaTEFFERI, Ayalew.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8520-8530, issn 0732-183X, 11 p.Article

Conventional and new treatment options for myelofibrosis with myeloid metaplasiaODENIKE, Olatoyosi; TEFFERI, Ayalew.Seminars in oncology. 2005, Vol 32, Num 4, pp 422-431, issn 0093-7754, 10 p.Article

The spleen in myelofibrosis with myeloid metaplasiaTEFFERI, Ayalew; NAGORNEY, David M.Mayo Clinic proceedings. 2004, Vol 79, Num 4, issn 0025-6196, p. 503Article

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for MyelofibrosisVERSTOVSEK, Srdan; MESA, Ruben A; TALPAZ, Moshe et al.The New England journal of medicine. 2012, Vol 366, Num 9, pp 799-807, issn 0028-4793, 9 p.Article

ASXL1 mutations in primary and secondary myelofibrosisRICCI, Clara; SPINELLI, Orietta; SALMOIRAGHI, Silvia et al.British journal of haematology. 2012, Vol 156, Num 3, pp 404-407, issn 0007-1048, 4 p.Article

Myelofibrosis with myeloid metaplasia : Diagnosis, prognostic factors, and stagingCERVANTES, Francisco; BAROSI, Giovanni.Seminars in oncology. 2005, Vol 32, Num 4, pp 395-402, issn 0093-7754, 8 p.Article

Perirenal extra medullary haematopoeisis in myelofibrosis demonstrated on computed tomographyABLETT, Mark J; VOSYLIUS, Pauline.British journal of haematology. 2004, Vol 124, Num 4, issn 0007-1048, p. 406Article

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndromeKLION, Amy D; ROBYN, Jamie; AKIN, Cem et al.Blood. 2004, Vol 103, Num 2, pp 473-478, issn 0006-4971, 6 p.Article

Myelofibrosis secondary to hyperparathyroidismKUMBASAR, B; TAYLAN, I; KAZANCIOGLU, R et al.Experimental and clinical endocrinology & diabetes. 2004, Vol 112, Num 3, pp 127-130, issn 0947-7349, 4 p.Article

Pomalidomide Is Active in the Treatment of Anemia Associated With MyelofibrosisTEFFERI, Ayalew; VERSTOVSEK, Srdan; THIELE, Juergen et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4563-4569, issn 0732-183X, 7 p.Article

Survival in young patients with intermediate-/high-risk myelofibrosis : Estimates derived from databases for non transplant patientsSIRAGUSA, Sergio; PASSAMONTI, Francesco; CERVANTES, Francisco et al.American journal of hematology. 2009, Vol 84, Num 3, pp 140-143, issn 0361-8609, 4 p.Article

Myelofibrosis with myeloid metaplasia: New developments in pathogenesis and treatmentDINGLI, David; MESA, Ruben A; TEFFERI, Ayalew et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 7, pp 540-547, issn 0918-2918, 8 p.Article

Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutationsLASHO, T. L; TEFFERI, A; FINKE, C et al.Leukemia. 2011, Vol 25, Num 6, pp 1056-1058, issn 0887-6924, 3 p.Article

Thrombocytopenia in Myelodysplastic Syndromes and MyelofibrosisBORUCHOV, Adam M.Seminars in hematology. 2009, Vol 46, Num 1, issn 0037-1963, S37-S43, SUP2Article

Peritoneal haematopoiesis in acute panmyelosis with myelofibrosisMETZGEROTH, Georgia; REITER, Andreas; BACK, Walter et al.British journal of haematology. 2005, Vol 130, Num 1, issn 0007-1048, p. 1Article

Modern management of myelofibrosisCERVANTES, Francisco.British journal of haematology. 2005, Vol 128, Num 5, pp 583-592, issn 0007-1048, 10 p.Article

Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasiaMESA, Ruben A; TEFFERI, Ayalew.Seminars in oncology. 2005, Vol 32, Num 4, pp 403-413, issn 0093-7754, 11 p.Article

Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasiaBAROSI, Giovanni; VITTORIO, Rosti; UMBERTO, Magrini et al.British journal of haematology. 2004, Vol 124, Num 5, pp 618-625, issn 0007-1048, 8 p.Article

Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasiaARORA, Brijesh; HO, Ching-Liang; HOYER, James D et al.Haematologica (Roma). 2004, Vol 89, Num 12, pp 1454-1458, issn 0390-6078, 5 p.Article

New approaches in the treatment of myelofibrosisHENNESSY, Bryan T; THOMAS, Deborah A; GILES, Francis J et al.Cancer. 2005, Vol 103, Num 1, pp 32-43, issn 0008-543X, 12 p.Article

Diagnostic et traitement de la splénomégalie myéloïde : Syndromes myéloprolifératifs = Myelofibrosis with myeloid metaplasia : diagnosis and treatment : Myeloproliferative disordersDUPRIEZ, Brigitte; DEMORY, Jean-Loup.La Revue du praticien (Paris). 2005, Vol 55, Num 15, pp 1680-1685, issn 0035-2640, 6 p.Article

Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasiaMESA, Ruben A; ELLIOTT, Michelle A; SCHROEDER, Georgene et al.Mayo Clinic proceedings. 2004, Vol 79, Num 7, pp 883-889, issn 0025-6196, 7 p.Article